Healthcare

NHS Restructuring: Ministers Consider Ring-Fencing Key Staff from Department of Health

An integrated care board's £1.6 million rescue of its local Healthwatch reveals how far NHS reform has pushed accountability onto whoever is left holding the budget.

As Washington pushes old allies to rethink familiar partnerships, Mark Carney’s standoff with the United States may open an unexpected door for Europe and the NHS. The real prize is not simply lower tariffs. It is the chance to build new routes for patient access, staff, technology, market entry, clinical research and the cost of medicines.

NHS England's refusal of Mid and South Essex's £94 million off-balance-sheet financing scheme reveals how tightly Whitehall now guards the boundary between public debt and private capital in a service starved of both.

NHS England's retreat on patient data access exposes a gap between the ambitions of centralised health data and the unglamorous work of governing who gets to look at it.

New community hubs and emergency departments mark an early domestic policy test for Yvette Cooper, while Somerset ICB's separate tender points to the smaller-scale procurement decisions now running alongside the national rollout.

Renewed theatre strikes at an enforcement-flagged trust raise questions about managerial consistency rather than clinical safety.

Authorisation of Eli Lilly's Foundayo marks a European regulatory first, but the drug's path onto NHS formularies now depends on how quickly NICE can complete its evaluation.